262 related articles for article (PubMed ID: 22788832)
1. Tolerability and safety of commonly used dietary supplements and nutraceuticals with lipid-lowering effects.
Cicero AF; Ferroni A; Ertek S
Expert Opin Drug Saf; 2012 Sep; 11(5):753-66. PubMed ID: 22788832
[TBL] [Abstract][Full Text] [Related]
2. An update on the safety of nutraceuticals and effects on lipid parameters.
Cicero AFG; Colletti A
Expert Opin Drug Saf; 2018 Mar; 17(3):303-313. PubMed ID: 29338456
[TBL] [Abstract][Full Text] [Related]
3. Lipid lowering with dietary supplements: focus on diabetes.
Rudkowska I
Maturitas; 2012 Jun; 72(2):113-6. PubMed ID: 22459005
[TBL] [Abstract][Full Text] [Related]
4. Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?
Cicero AFG; Fogacci F; Stoian AP; Vrablik M; Al Rasadi K; Banach M; Toth PP; Rizzo M
Curr Atheroscler Rep; 2021 Aug; 23(10):57. PubMed ID: 34345932
[TBL] [Abstract][Full Text] [Related]
5. Nutraceuticals in lipid-lowering treatment: a narrative review on the role of chitosan.
Patti AM; Katsiki N; Nikolic D; Al-Rasadi K; Rizzo M
Angiology; 2015 May; 66(5):416-21. PubMed ID: 25037700
[TBL] [Abstract][Full Text] [Related]
6. Lipid-modifying effects of nutraceuticals: An evidence-based approach.
Sahebkar A; Serban MC; Gluba-Brzózka A; Mikhailidis DP; Cicero AF; Rysz J; Banach M
Nutrition; 2016; 32(11-12):1179-92. PubMed ID: 27324061
[TBL] [Abstract][Full Text] [Related]
7. Pharmacology of Nutraceuticals with Lipid Lowering Properties.
Poli A; Visioli F
High Blood Press Cardiovasc Prev; 2019 Apr; 26(2):113-118. PubMed ID: 30877602
[TBL] [Abstract][Full Text] [Related]
8. [Nutraceuticals: a useful tool for cardiologists to improve lipid profile?].
Covolo E; Bilato C
G Ital Cardiol (Rome); 2018 Feb; 19(2):81-90. PubMed ID: 29531380
[TBL] [Abstract][Full Text] [Related]
9. Nutraceuticals in cardiovascular prevention: lessons from studies on endothelial function.
Zuchi C; Ambrosio G; Lüscher TF; Landmesser U
Cardiovasc Ther; 2010 Aug; 28(4):187-201. PubMed ID: 20553294
[TBL] [Abstract][Full Text] [Related]
10. Nutraceuticals and atherosclerosis: human trials.
Badimon L; Vilahur G; Padro T
Cardiovasc Ther; 2010 Aug; 28(4):202-15. PubMed ID: 20633023
[TBL] [Abstract][Full Text] [Related]
11. The Possible Role of Nutraceuticals in the Prevention of Cardiovascular Disease.
Rivellese AA; Ciciola P; Costabile G; Vetrani C; Vitale M
High Blood Press Cardiovasc Prev; 2019 Apr; 26(2):101-111. PubMed ID: 30811011
[TBL] [Abstract][Full Text] [Related]
12. Effects of lipid-lowering therapy on reduction of cardiovascular events in patients with end-stage renal disease requiring hemodialysis.
Marrs JC; Saseen JJ
Pharmacotherapy; 2010 Aug; 30(8):823-9. PubMed ID: 20653359
[TBL] [Abstract][Full Text] [Related]
13. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
14. Nutraceuticals for the treatment of hypercholesterolemia.
Mannarino MR; Ministrini S; Pirro M
Eur J Intern Med; 2014 Sep; 25(7):592-9. PubMed ID: 24997485
[TBL] [Abstract][Full Text] [Related]
15. Nutraceuticals in the early infancy.
Pignatelli P; Basili S
Cardiovasc Ther; 2010 Aug; 28(4):236-45. PubMed ID: 20553293
[TBL] [Abstract][Full Text] [Related]
16. Current evidence and future perspectives of omega-3 polyunsaturated fatty acids for the prevention of cardiovascular disease.
Rizos EC; Elisaf MS
Eur J Pharmacol; 2013 Apr; 706(1-3):1-3. PubMed ID: 23499683
[TBL] [Abstract][Full Text] [Related]
17. Cholesterol-Lowering Nutraceuticals Affecting Vascular Function and Cardiovascular Disease Risk.
Bianconi V; Mannarino MR; Sahebkar A; Cosentino T; Pirro M
Curr Cardiol Rep; 2018 May; 20(7):53. PubMed ID: 29802549
[TBL] [Abstract][Full Text] [Related]
18. Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: The available clinical data.
Cicero AF; Colletti A
Phytomedicine; 2016 Oct; 23(11):1113-8. PubMed ID: 26621556
[TBL] [Abstract][Full Text] [Related]
19. The role of cellular micronutrient analysis, nutraceuticals, vitamins, antioxidants and minerals in the prevention and treatment of hypertension and cardiovascular disease.
Houston MC
Ther Adv Cardiovasc Dis; 2010 Jun; 4(3):165-83. PubMed ID: 20400494
[TBL] [Abstract][Full Text] [Related]
20. Cholesterol-Lowering Bioactive Foods and Nutraceuticals in Pediatrics: Clinical Evidence of Efficacy and Safety.
Fogacci F; ALGhasab NS; Di Micoli V; Giovannini M; Cicero AFG
Nutrients; 2024 May; 16(10):. PubMed ID: 38794764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
